observation group, the use of micro-channel percutaneous nephrolithotomy lithotripsy; and 48 cases of patients with urolithiasis in March 2013~December 2013 were treated as the control group, the use of open stone surgery treatment. Results: It was observed in patients with clinical manifestations and complications during surgery, after statistical comparison of the results were analyzed. Observation group and control group operative time was no difference (P>0.05), hospitalization time in the observation group was shorter than the control group (P<0.05). Bleeding volume in the observation group was less than the control group (P<0.05). A clearance rate in the observation group was higher than the control group (P<0.05), the incidence of complications in the observation group was less than the control group (P<0.05).
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Conclusion:
The difference was statistically significant. Significant effect of microchannel percutaneous nephrolithotomy is smaller surgical trauma and shorter hospital stay. Objective: Renal transplantation is considered to be the preferred treatment comparing with dialysis. However, the inherent risk of renal transplantation brings lifelong regimen of immunosuppressive medication and active surveillance. It is known that poor compliance can increase 60% risk of graft failure. Intervention targeting behavioral risk factors or a combination of behavioral, educational and emotional changes has positive effect in medication adherence. These interventions need to be utilized by a well-established and organized healthcare system. In China, most of living donor renal transplantation recipients are from rural area which is still facing healthcare shortages. We found some of post-transplanted patients were using smartphone apps to manage their medication to avoid medication missing. The present retrospective study is to discuss the feasibility of smartphone app on medical compliance intervention in living donor renal transplantation patients in China. Methods: A total of 100 living donor recipients who were followed up in our hospital regularly were involved in this study. For the first step, we designed a questionnaire to survey demographic data and whether they were using smartphone app to manage their medications. Then we compared the medical adherence between the patients using and not using smartphone apps. Basel Assessment of Adherence to Immunosuppressive Medications Scale (BAASIS) was applied to evaluate the medical adherence. We also investigated the willing of using smartphone apps to manage the medication in living donor renal transplanted recipients. Descriptive statistics were calculated to describe survey item response. Results: A total of 94% of recruited patients (94 of 100) participated. Twenty-three cases (Group A, 24.5%) were using smartphone apps to manage their medication and the rest 71 cases were not (Group B, 75.5%). When comparing group A and B, it showed the younger and well educated patients had more willing to use smartphone apps to remind their medication. In China, living area is a good marker to reflect the patients' socioeconomic factors which were considered to be one of major influencing factors of medical adherence. Thus, according to regional differences, 1:1 stratified sampling was performed to randomly select 23 cases in group B as group C. Comparing with group C, Group A showed better medical adherence (P=0.049), but no difference in age, education level, renal function and immunosuppressive regimen. It showed smartphone app could enhance immunosuppressive medication adherence. In willingness investigation, most recipients owned smartphone (91.5%), 71.8% patients has strong demand for medication management equipment while more than half patients reported they would be willing to manage their medication via smartphone apps. Conclusions: our study demonstrated the smartphonebased medication management may be able to be an effective intervention to improve the living donor renal transplantation patients' compliance. Most recipients were willing to adopt smartphone-based post-operative medication reminder. Further studies will focus on smartphone app design and discuss whether smartphone based medical adherence intervention could improve the long-term outcomes of renal transplantation. Objective: To identify the relative factors of female patients with primary overactive bladder. To determine whether medical interfered-pelvic floor muscle training and behavioral therapy can enhance the treatment effects of tolterodine on female patients with primary overactive bladder (OAB). Methods: A total of 107 women from one center with primary overactive bladder under the treatment with tolterodine extended release tablets (5 mg once daily) were randomly divided to an experiment (E) group (interfered with pelvic floor muscle training, PFMT, three sessions per day, 15-20 times/session, n=54), and a control (C) group (interfered with general health education, n=53). The total intervention was 3 months. Followed up after 6 months. Treatment efficacy was measured by micturition diary, Oxford pelvic floor muscle force scores, OABSS scores and patients' subjective KHQ quality of life scores respectively at baseline, 2 weeks, 1 month and 3 months. Results: female OAB were related to age, marriage, delivery mode and times, body mass index and chronic disease (P<0.05). There were no significant correlation with education level, place of residence, abortion and food habits (P>0.05). At 1 and 3 months, both of the groups had a decreased OABSS and KHQ scores than before. At 3 months, the E group showed an enhanced pelvic muscle force than C group (P<0.05), but no significant difference on OABSS scores (P>0.05). In quality of life, E group showed significant decrease on micturition severity, role limitations, physical/social limitations and emotions domains (P<0.05). At 6 months Followed up, there was a statistically significant difference of OABSS scores and KHQ scores in all ten domains between two groups (P<0.05).
The risk factors of female primary OAB were related to age, marriage, delivery mode and times, body mass index and chronic disease .OAB seriously affect the quality of life of patients. PFMT can significantly improve pelvic floor muscle strength, and enhance the tolterodine treatment effect. Three months short term treatment is not enough to relieve the OAB symptoms and improve the quality of life completely. Long-term (6 months) treatment can be effectively. 
